Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Novartis AG (ADR) - SIC # 2834 - PHARMACEUTICAL PREPARATIONS
Ticker
Exchange
SIC #
Website
Latest Ticker
NVS
New York
2834
https://www.novartis.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Novartis AG (ADR)
Alnylam (ALNY) Q1 Loss Narrower Than Expected, Sales Rise Y/Y
- May 3rd, 2024 4:29 pm
Why selling to Novartis made sense for Mariana
- May 3rd, 2024 12:15 pm
Top Midday Stories: Novo Nordisk, Linde Shares Fall Post-Earnings; Peloton Shares Plummet After Announcing Job Cuts, CEO Change; Exxon-Pioneer Deal Gets FTC Approval With One Caveat
- May 2nd, 2024 3:54 pm
Novartis to buy Mariana Oncology in radiopharmaceutical expansion
- May 2nd, 2024 12:20 pm
UPDATE 2-Novartis to buy radiology drug specialist Mariana for $1 billion
- May 2nd, 2024 11:30 am
The top pharmaceutical companies by R&D expenditure
- May 2nd, 2024 7:01 am
CVS stock plunges after earnings numbers one analyst 'did not even believe'
- May 1st, 2024 5:46 pm
Novartis Is Tracking Well Above the Industry
- May 1st, 2024 2:00 pm
Update: FTC Challenging 'Junk' Patent Listings for Ozempic, Victoza, Other Medications
- Apr 30th, 2024 3:50 pm
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
- Apr 30th, 2024 1:50 pm
Why This 1 Value Stock Could Be a Great Addition to Your Portfolio
- Apr 29th, 2024 1:40 pm
Pharma Stock Roundup: MRK, SNY, AZN, NVS' Q1 Results, Pipeline & Regulatory Updates
- Apr 26th, 2024 3:34 pm
Why Big Pharma Is Following Novartis' Lead In A $25 Billion Market
- Apr 25th, 2024 12:30 pm
Novartis bags paediatric FDA label expansion for Lutathera
- Apr 24th, 2024 3:42 pm
Novartis AG (NYSE:NVS) Q1 2024 Earnings Call Transcript
- Apr 24th, 2024 2:30 pm
Company News for Apr 24, 2024
- Apr 24th, 2024 1:36 pm
Novartis and Medicines for Malaria Venture announce positive efficacy and safety data for a novel treatment for babies <5 kg with malaria
- Apr 24th, 2024 4:30 am
Why Novartis Stock Topped the Market on Tuesday
- Apr 23rd, 2024 10:25 pm
FDA Approves Novartis' Lutathera As First Therapy For Pediatric Patients With Gastroenteropancreatic Neuroendocrine Tumors
- Apr 23rd, 2024 9:05 pm
How Novartis Rode Two Blockbuster Drugs To Its Beat And Raise, And Three-Day Sprint
- Apr 23rd, 2024 8:01 pm
Scroll